Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Chubb
Farmers Insurance
Colorcon
Cipla
McKesson
Express Scripts
Moodys
Covington
Accenture

Generated: August 21, 2017

DrugPatentWatch Database Preview

PROVENTIL Drug Profile

« Back to Dashboard

What is the patent landscape for Proventil, and when can generic versions of Proventil launch?

Proventil is a drug marketed by Schering and 3m Drug Delivery and is included in six NDAs. There is one patent protecting this drug and one Paragraph IV challenge.

The generic ingredient in PROVENTIL is albuterol. There are thirty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the albuterol profile page.

Summary for Tradename: PROVENTIL

Patents:0
Applicants:2
NDAs:6
Bulk Api Vendors: see list73
Clinical Trials: see list13
Patent Applications: see list6,445
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROVENTIL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
PROVENTIL
albuterol sulfate
SOLUTION;INHALATION019243-002Jan 14, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
PROVENTIL
albuterol sulfate
TABLET, EXTENDED RELEASE;ORAL019383-001Jul 13, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
PROVENTIL
albuterol sulfate
TABLET;ORAL017853-002May 7, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
3m Drug Delivery
PROVENTIL-HFA
albuterol sulfate
AEROSOL, METERED;INHALATION020503-001Aug 15, 1996BXRXYesYes► Subscribe► SubscribeY ► Subscribe
Schering
PROVENTIL
albuterol sulfate
SOLUTION;INHALATION019243-001Jan 14, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROVENTIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
PROVENTIL
albuterol sulfate
SYRUP;ORAL018062-001Jan 19, 1983► Subscribe► Subscribe
Schering
PROVENTIL
albuterol sulfate
TABLET, EXTENDED RELEASE;ORAL019383-001Jul 13, 1987► Subscribe► Subscribe
Schering
PROVENTIL
albuterol sulfate
TABLET;ORAL017853-002May 7, 1982► Subscribe► Subscribe
Schering
PROVENTIL
albuterol
AEROSOL, METERED;INHALATION017559-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Schering
PROVENTIL
albuterol sulfate
SOLUTION;INHALATION019243-002Jan 14, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: PROVENTIL

Drugname Dosage Strength RLD Submissiondate
albuterol sulfateInhalation Aerosol 0.09 mg base per actuation Proventil HFA 5/20/2015
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Covington
Deloitte
Healthtrust
QuintilesIMS
Teva
Johnson and Johnson
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot